Understanding Patient and Physician Perspectives Regarding Innovative Research in Rheumatoid Arthritis
Patients and physicians shared their concerns regarding how being part of research in the setting of clinical care could disrupt day-to-day activities and threaten shared decision making. Understanding patients' and physicians' perspectives regarding pRCT and biomarker-driven trials is key to enhance the success of these research innovations.
Authors
- Catney Charles
- Sandra Peláez (ORCID: https://orcid.org/0000-0002-0539-4075)
- Sasha Bernatsky (ORCID: https://orcid.org/0000-0002-9515-2802)
- Melanie C. Baniña (ORCID: https://orcid.org/0000-0002-6055-0229)
- Inés Colmegna (ORCID: https://orcid.org/0000-0002-8091-8334)
- Marie Hudson (ORCID: https://orcid.org/0000-0001-6718-2468)
- Radhika Prabhune
Institutions
- Hudson Institute (US)
- Charles River Laboratories (Netherlands) (NL)
- McGill University Health Centre (CA)
- Jewish General Hospital (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Veterinarians Without Borders (US)
- Pratt Institute (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-09-15
- DOI
- https://doi.org/10.3899/jrheum.2025-0510
- Primary Topic
- Health and Medical Research Impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00